These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22392419)

  • 1. Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician.
    Bungard TJ; Ritchie B; Garg S; Tsuyuki RT
    Pharmacotherapy; 2012 Feb; 32(2):112-9. PubMed ID: 22392419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two different models of anticoagulation management services with usual medical care.
    Rudd KM; Dier JG
    Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial.
    Wilson SJ; Wells PS; Kovacs MJ; Lewis GM; Martin J; Burton E; Anderson DR
    CMAJ; 2003 Aug; 169(4):293-8. PubMed ID: 12925422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
    Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
    Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial.
    Verret L; Couturier J; Rozon A; Saudrais-Janecek S; St-Onge A; Nguyen A; Basmadjian A; Tremblay S; Brouillette D; de Denus S
    Pharmacotherapy; 2012 Oct; 32(10):871-9. PubMed ID: 23033226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH; Wheeldon NM
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.
    Chan FW; Wong RS; Lau WH; Chan TY; Cheng G; You JH
    Br J Clin Pharmacol; 2006 Nov; 62(5):601-9. PubMed ID: 17061966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of an inpatient anticoagulation management service on clinical outcomes.
    Biscup-Horn PJ; Streiff MB; Ulbrich TR; Nesbit TW; Shermock KM
    Ann Pharmacother; 2008 Jun; 42(6):777-82. PubMed ID: 18460587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcomes using 2 delivery models of anticoagulation care.
    Staresinic AG; Sorkness CA; Goodman BM; Pigarelli DW
    Arch Intern Med; 2006 May; 166(9):997-1002. PubMed ID: 16682573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
    Burkiewicz JS
    Pharmacotherapy; 2005 Aug; 25(8):1062-7. PubMed ID: 16207096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
    Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
    J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome analysis of a pharmacist-managed anticoagulation service.
    Wilt VM; Gums JG; Ahmed OI; Moore LM
    Pharmacotherapy; 1995; 15(6):732-9. PubMed ID: 8602380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.